United States Antibacterial Drug Resistance Industry 2017 Market Research Report

 Table of Contents

United States Antibacterial Drug Resistance Market Report 2017
1 Antibacterial Drug Resistance Overview
    1.1 Product Overview and Scope of Antibacterial Drug Resistance
    1.2 Classification of Antibacterial Drug Resistance
        1.2.1 Telavancin (Vibativ?)
        1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        1.2.3 Fidaxomicin (Dificid / Dificlir?)
        1.2.4 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
        1.2.5 Dalbavancin (Dalvance? / Xydalba?)
        1.2.6 Tedizolid Phosphate (Sivextro?)
        1.2.7 Oritavancin (Orbactiv? / Nuvocid?)
        1.2.8 Ceftolozane-Tazobactam (Zerbaxa?)
        1.2.9 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
        1.2.10 PHASE III DRUGS
    1.3 Application of Antibacterial Drug Resistance
        1.3.1 Gram-Positive
        1.3.2 Gram-Negative
    1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antibacterial Drug Resistance (2012-2022)
        1.4.1 United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
        1.4.2 United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 United States Antibacterial Drug Resistance Competition by Manufacturers
    2.1 United States Antibacterial Drug Resistance Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States Antibacterial Drug Resistance Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States Antibacterial Drug Resistance Average Price by Manufactures (2015 and 2016)
    2.4 Antibacterial Drug Resistance Market Competitive Situation and Trends
        2.4.1 Antibacterial Drug Resistance Market Concentration Rate
        2.4.2 Antibacterial Drug Resistance Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States Antibacterial Drug Resistance Sales (Volume) and Revenue (Value) by States (2012-2017)
    3.1 United States Antibacterial Drug Resistance Sales and Market Share by States (2012-2017)
    3.2 United States Antibacterial Drug Resistance Revenue and Market Share by States (2012-2017)
    3.3 United States Antibacterial Drug Resistance Price by States (2012-2017)

4 United States Antibacterial Drug Resistance Sales (Volume) and Revenue (Value) by Type (2012-2017)
    4.1 United States Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
    4.2 United States Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
    4.3 United States Antibacterial Drug Resistance Price by Type (2012-2017)
    4.4 United States Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)

5 United States Antibacterial Drug Resistance Sales (Volume) by Application (2012-2017)
    5.1 United States Antibacterial Drug Resistance Sales and Market Share by Application (2012-2017)
    5.2 United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 United States Antibacterial Drug Resistance Manufacturers Profiles/Analysis
    6.1 AAIPharma Services
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.1.2.1 Telavancin (Vibativ?)
            6.1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 ANTABIO
        6.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.2.2.1 Telavancin (Vibativ?)
            6.2.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abgentis
        6.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.3.2.1 Telavancin (Vibativ?)
            6.3.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abbott Laboratories
        6.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.4.2.1 Telavancin (Vibativ?)
            6.4.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Absynth Biologics
        6.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.5.2.1 Telavancin (Vibativ?)
            6.5.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Achaogen
        6.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.6.2.1 Telavancin (Vibativ?)
            6.6.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Acino Holdings
        6.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.7.2.1 Telavancin (Vibativ?)
            6.7.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Aventis Pharma
        6.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.8.2.1 Telavancin (Vibativ?)
            6.8.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Austell Laboratories
        6.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.9.2.1 Telavancin (Vibativ?)
            6.9.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Assembly Biosciences
        6.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
            6.10.2.1 Telavancin (Vibativ?)
            6.10.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
        6.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Arpida
    6.12 Demuris
    6.13 Evolva Holding
    6.14 ContraFect
    6.15 Cerexa
    6.16 GSK
    6.17 InterMune
    6.18 Isis Pharmaceuticals
    6.19 Lyndra
    6.20 Microbecide
    6.21 Morphochem
    6.22 Nabriva Therapeutics
    6.23 NanoSafe Coatings
    6.24 Novexel
    6.25 Osel
    6.26 PENDOPHARM
    6.27 Pfizer
    6.28 VenatoRx Pharmaceuticals

7 Antibacterial Drug Resistance Manufacturing Cost Analysis
    7.1 Antibacterial Drug Resistance Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Antibacterial Drug Resistance Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Antibacterial Drug Resistance Market Forecast (2017-2022)
    11.1 United States Antibacterial Drug Resistance Sales, Revenue Forecast (2017-2022)
    11.2 United States Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
    11.3 United States Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)
    11.4 Antibacterial Drug Resistance Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures 

    Figure Picture of Antibacterial Drug Resistance
    Table Classification of Antibacterial Drug Resistance
    Figure United States Sales Market Share of Antibacterial Drug Resistance by Type in 2015
    Figure Telavancin (Vibativ?) Picture
    Figure Ceftaroline Fosamil (Teflaro? / Zinforo) Picture
    Figure Fidaxomicin (Dificid / Dificlir?) Picture
    Figure Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?) Picture
    Figure Dalbavancin (Dalvance? / Xydalba?) Picture
    Figure Tedizolid Phosphate (Sivextro?) Picture
    Figure Oritavancin (Orbactiv? / Nuvocid?) Picture
    Figure Ceftolozane-Tazobactam (Zerbaxa?) Picture
    Figure Ceftazidime-Avibactam (Avycaz? / Zavicefta) Picture
    Figure PHASE III DRUGS Picture
    Table Application of Antibacterial Drug Resistance
    Figure United States Sales Market Share of Antibacterial Drug Resistance by Application in 2015
    Figure Gram-Positive Examples
    Figure Gram-Negative Examples
    Figure United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
    Figure United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
    Table United States Antibacterial Drug Resistance Sales of Key Manufacturers (2015 and 2016)
    Table United States Antibacterial Drug Resistance Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 Antibacterial Drug Resistance Sales Share by Manufacturers
    Figure 2016 Antibacterial Drug Resistance Sales Share by Manufacturers
    Table United States Antibacterial Drug Resistance Revenue by Manufacturers (2015 and 2016)
    Table United States Antibacterial Drug Resistance Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 United States Antibacterial Drug Resistance Revenue Share by Manufacturers
    Table 2016 United States Antibacterial Drug Resistance Revenue Share by Manufacturers
    Table United States Market Antibacterial Drug Resistance Average Price of Key Manufacturers (2015 and 2016)
    Figure United States Market Antibacterial Drug Resistance Average Price of Key Manufacturers in 2015
    Figure Antibacterial Drug Resistance Market Share of Top 3 Manufacturers
    Figure Antibacterial Drug Resistance Market Share of Top 5 Manufacturers
    Table United States Antibacterial Drug Resistance Sales by States (2012-2017)
    Table United States Antibacterial Drug Resistance Sales Share by States (2012-2017)
    Figure United States Antibacterial Drug Resistance Sales Market Share by States in 2015
    Table United States Antibacterial Drug Resistance Revenue and Market Share by States (2012-2017)
    Table United States Antibacterial Drug Resistance Revenue Share by States (2012-2017)
    Figure Revenue Market Share of Antibacterial Drug Resistance by States (2012-2017)
    Table United States Antibacterial Drug Resistance Price by States (2012-2017)
    Table United States Antibacterial Drug Resistance Sales by Type (2012-2017)
    Table United States Antibacterial Drug Resistance Sales Share by Type (2012-2017)
    Figure United States Antibacterial Drug Resistance Sales Market Share by Type in 2015
    Table United States Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
    Table United States Antibacterial Drug Resistance Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Antibacterial Drug Resistance by Type (2012-2017)
    Table United States Antibacterial Drug Resistance Price by Type (2012-2017)
    Figure United States Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)
    Table United States Antibacterial Drug Resistance Sales by Application (2012-2017)
    Table United States Antibacterial Drug Resistance Sales Market Share by Application (2012-2017)
    Figure United States Antibacterial Drug Resistance Sales Market Share by Application in 2015
    Table United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
    Figure United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
    Table AAIPharma Services Basic Information List
    Table AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Figure AAIPharma Services Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table ANTABIO Basic Information List
    Table ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table ANTABIO Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Abgentis Basic Information List
    Table Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Abgentis Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Abbott Laboratories Basic Information List
    Table Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Abbott Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Absynth Biologics Basic Information List
    Table Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Absynth Biologics Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Achaogen Basic Information List
    Table Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Achaogen Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Acino Holdings Basic Information List
    Table Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Acino Holdings Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Aventis Pharma Basic Information List
    Table Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Aventis Pharma Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Austell Laboratories Basic Information List
    Table Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Austell Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Assembly Biosciences Basic Information List
    Table Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Assembly Biosciences Antibacterial Drug Resistance Sales Market Share (2012-2017)
    Table Arpida Basic Information List
    Table Demuris Basic Information List
    Table Evolva Holding Basic Information List
    Table ContraFect Basic Information List
    Table Cerexa Basic Information List
    Table GSK Basic Information List
    Table InterMune Basic Information List
    Table Isis Pharmaceuticals Basic Information List
    Table Lyndra Basic Information List
    Table Microbecide Basic Information List
    Table Morphochem Basic Information List
    Table Nabriva Therapeutics Basic Information List
    Table NanoSafe Coatings Basic Information List
    Table Novexel Basic Information List
    Table Osel Basic Information List
    Table PENDOPHARM Basic Information List
    Table Pfizer Basic Information List
    Table VenatoRx Pharmaceuticals Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Antibacterial Drug Resistance
    Figure Manufacturing Process Analysis of Antibacterial Drug Resistance
    Figure Antibacterial Drug Resistance Industrial Chain Analysis
    Table Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
    Table Major Buyers of Antibacterial Drug Resistance
    Table Distributors/Traders List
    Figure United States Antibacterial Drug Resistance Production and Growth Rate Forecast (2017-2022)
    Figure United States Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
    Table United States Antibacterial Drug Resistance Production Forecast by Type (2017-2022)
    Table United States Antibacterial Drug Resistance Consumption Forecast by Application (2017-2022)
    Table United States Antibacterial Drug Resistance Sales Forecast by States (2017-2022)
    Table United States Antibacterial Drug Resistance Sales Share Forecast by States (2017-2022)

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy